Clinical Trial

Lactic Acid Bacteria for Reducing Blue Light-Induced Eye Fatigue

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
With the widespread use of digital devices and prolonged screen exposure, digital eye strain (DES), also known as computer vision syndrome, has become a global public health concern. Emerging evidence suggests that the gut-eye axis may play an important role in ocular health, as gut microbiota imbalance is associated with systemic inflammation and oxidative stress. Specific probiotics may help alleviate eye discomfort through modulation of immune responses and enhancement of antioxidant defense mechanisms. This randomized, double-blind, placebo-controlled study aims to evaluate the efficacy of supplementation with specific probiotics, Bifidobacterium longum BL531 and Lactobacillus reuteri LR1349, in improving digital eye strain symptoms in adults.
Trial Details
NCT Number NCT07737938
Lead Sponsor Synbio Tech Inc.
Conditions Digital Eye Strain (DES)
Enrollment 150 participants
Start Date 2026-09-01
Primary Completion 2027-08-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-30